KETOROLAC TROMETAMOL

Ketorolac Tromethamine is a potent non-steroidal anti-inflammatory drug (NSAID) that has been studied extensively in various clinical settings. This medication works primarily by inhibiting the synthesis of prostaglandins, which are key mediators of pain and inflammation in the body. Clinical trials have explored multiple administration routes for ketorolac, including intravenous, intranasal, topical, and oral formulations, demonstrating its versatility across different patient populations and conditions. From acute pain management in emergency settings to postoperative care and chronic conditions, ketorolac offers a non-opioid alternative that may help reduce reliance on potentially addictive pain medications while providing effective relief. This article summarizes the key findings from recent clinical trials investigating the efficacy, safety, and optimal dosing of ketorolac tromethamine in various clinical applications.

Table of Contents

What is Ketorolac Tromethamine?

Ketorolac Tromethamine is a powerful non-steroidal anti-inflammatory drug (NSAID) that belongs to a group of non-opioid analgesics. It works by inhibiting the synthesis of prostaglandins and thromboxanes, which are substances in the body responsible for inflammation, pain, and fever. Unlike opioid pain medications, Ketorolac does not cause dependency or addiction, making it a valuable alternative for pain management in many clinical situations [1].

The drug is also known by several other names, including simply “ketorolac,” “Toradol,” “Acular LS” (ophthalmic solution), “Sprix” (intranasal spray), and “Lacribell” (ophthalmic solution) [1][2]. These different names often correspond to different formulations of the medication, which are designed for specific routes of administration.

Medical Uses

Ketorolac Tromethamine is used to treat various painful conditions. Based on clinical trials, it has shown effectiveness in treating:

  • Acute renal colic – severe pain caused by kidney stones [3]
  • Postoperative pain – pain following surgery [4]
  • Migraine headaches – severe, throbbing headaches often accompanied by nausea and sensitivity to light [5]
  • Acute pain from inflammation – such as pain from arthritis [6]
  • Acute gouty arthritis – painful inflammation of a joint due to deposits of uric acid crystals [7]
  • Open angle glaucoma – as an anti-inflammatory agent following laser treatment [8]
  • Interstitial cystitis – a chronic condition causing bladder pressure and pain [9]
  • Low back pain – when applied as a gel for external use [10]

Ketorolac is particularly valuable in clinical settings where rapid pain relief is needed but opioids need to be avoided or minimized. It’s often used as part of a multimodal approach to pain management, meaning it can be used alongside other pain medications to provide better relief with fewer side effects [1].

Administration Routes

One of the notable features of Ketorolac Tromethamine is the variety of ways it can be administered, making it versatile for different clinical situations:

  • Intravenous (IV) – Direct injection into a vein, often used in hospital settings for quick pain relief [1]
  • Intranasal (IN) – As a nasal spray (marketed as Sprix), providing a needle-free option [11]
  • Oral – Taken by mouth as tablets [12]
  • Ophthalmic – Eye drops (marketed as Acular LS), used after eye surgery or for treating inflammation [8]
  • Topical – Applied to the skin as a gel for localized pain relief [7]

The intranasal form of ketorolac (Sprix) has been studied extensively and provides a convenient alternative to injections. When administered nasally, ketorolac is quickly absorbed into the bloodstream through the nasal tissues, providing rapid pain relief without the need for needles [4]. Studies have examined different administration techniques for intranasal ketorolac, including gentle versus vigorous sniffing, to determine the best method for delivering the medication [13].

Effectiveness in Pain Management

Clinical trials have demonstrated that Ketorolac Tromethamine is effective for managing moderate to severe pain in various conditions. For example:

  • In patients with acute renal colic (kidney stone pain), ketorolac has been shown to provide significant pain relief when compared to baseline pain scores. It’s often used in emergency departments for this purpose [14].
  • For postoperative pain, studies show that ketorolac can reduce the need for opioid medications. In one study, patients who received ketorolac required less morphine for pain control after surgery [15].
  • In the treatment of migraine headaches, intranasal ketorolac has demonstrated effectiveness in reducing pain compared to placebo [5].
  • For eye surgery, ophthalmic ketorolac has been shown to reduce inflammation and pain while potentially preventing complications like cystoid macular edema [2].

A key finding from several studies is that ketorolac demonstrates a “ceiling effect” with its analgesic (pain-relieving) properties. This means that beyond a certain dose, increasing the amount of medication doesn’t provide additional pain relief but may increase the risk of side effects. For example, one study found that a lower dose of 15 mg intravenous ketorolac was just as effective as the standard 30 mg dose for postoperative pain management [1].

Dosing Information

The dosage of Ketorolac Tromethamine varies depending on the route of administration, the patient’s age, weight, and medical condition. Here are some general guidelines based on clinical trial information:

  • Intravenous (IV):
    • Adults: 15-30 mg per dose, with the lower dose (15 mg) often being just as effective with fewer side effects [1]
  • Intranasal (Sprix):
    • Adults: 31.5 mg (one 15.75 mg spray in each nostril) every 6-8 hours as needed [9]
    • Children weighing ≥50 kg: 30 mg [4]
    • Children weighing <50 kg: 15 mg [4]
  • Oral:
    • Adults: 10 mg every 4-6 hours, not to exceed 40 mg per day [12]
  • Topical gel:
    • Apply a 3-5 cm strip of gel to the affected area 3 times daily [10]

It’s important to note that ketorolac is generally intended for short-term use only (typically 5 days or less), as prolonged use increases the risk of side effects [12]. Always follow your healthcare provider’s instructions regarding dosage and duration of treatment.

Safety Profile

While Ketorolac Tromethamine is effective for pain management, like all medications, it comes with potential side effects and safety considerations. Understanding these can help patients use the medication safely.

Common side effects may include:

  • Gastrointestinal issues (stomach pain, indigestion) [14]
  • Nasal discomfort or irritation (with intranasal formulation) [11]
  • Drowsiness or dizziness [1]
  • Headache [5]

Less common but more serious side effects may include:

  • Gastrointestinal bleeding [14]
  • Kidney problems [14]
  • Allergic reactions [14]
  • Increased risk of cardiovascular events (heart attack, stroke) [14]

Studies have evaluated the tolerability of different formulations of ketorolac. For example, one study looked at the tolerability of intranasal ketorolac with different concentrations of lidocaine (a local anesthetic) to reduce nasal discomfort during administration [11]. Another study examined whether lower doses of intravenous ketorolac (15 mg vs. 30 mg) could provide similar pain relief with fewer side effects [1].

Precautions and contraindications: Ketorolac should be used with caution or avoided in people with:

  • History of peptic ulcer disease or gastrointestinal bleeding [14]
  • Kidney disease or risk of renal failure [14]
  • Bleeding disorders or those taking blood thinners [14]
  • Severe heart failure [14]
  • Pregnancy, especially in the third trimester [16]

Special Populations

Research has examined how Ketorolac Tromethamine works in different patient populations:

Children and Adolescents

Studies have investigated the use of ketorolac in pediatric patients, with specific dosing adjustments based on weight. For example, one study examined intranasal ketorolac for postoperative pain in children aged 12-17 years, using 15 mg for those weighing less than 50 kg and 30 mg for those weighing 50 kg or more [4]. Another study looked at ketorolac dosing in children from 0-11 years old undergoing surgical procedures, with weight-based dosing ranging from 3.15 mg to 31.5 mg [17].

Elderly Patients

Pharmacokinetic studies have compared how ketorolac is processed in the bodies of elderly versus non-elderly adults. These studies help determine whether dose adjustments are needed for older patients. Generally, elderly patients may be more sensitive to the effects of ketorolac and may require lower doses [18].

Pregnant Women

One study examined the disposition (how the drug moves through the body) of intravenous ketorolac after cesarean section to understand how pregnancy affects the metabolism of the drug. This research also aimed to quantify how much ketorolac might be transferred to a newborn through breast milk [16]. Generally, ketorolac is not recommended during pregnancy, especially in the third trimester.

Comparison with Other Pain Medications

Understanding how Ketorolac Tromethamine compares to other pain medications can help patients and healthcare providers make informed decisions about pain management:

Ketorolac vs. Opioids

Unlike opioid medications (such as morphine, oxycodone, or hydrocodone), ketorolac:

  • Does not cause dependency or addiction [1]
  • Doesn’t cause respiratory depression (slowed breathing) [1]
  • Causes less sedation and drowsiness [1]
  • Has fewer effects on gastrointestinal motility (less constipation) [1]

Studies have shown that using ketorolac can reduce the need for opioids after surgery. For example, one study found that patients who received ketorolac required significantly less morphine for postoperative pain control [15].

Ketorolac vs. Other NSAIDs

Compared to other NSAIDs (like ibuprofen or naproxen), ketorolac:

  • Is generally more potent for pain relief [1]
  • Is available in more routes of administration (IV, intranasal, etc.) [13]
  • Is typically limited to short-term use (5 days or less) due to side effect concerns [12]

One comparative study examined the effectiveness of ketorolac gel versus ketoprofen gel for treating gonarthrosis (knee arthritis) and low back pain, providing insights into how these topical NSAIDs compare [10].

Ketorolac vs. Steroids

In some contexts, such as treating inflammation after eye surgery, ketorolac has been compared to corticosteroids like prednisolone. While both reduce inflammation, they work through different mechanisms:

  • Ketorolac primarily inhibits the cyclooxygenase pathway [8]
  • Corticosteroids inhibit both the cyclooxygenase and lipoxygenase pathways [8]
  • Steroids may have more significant side effects with long-term use (increased eye pressure, cataract formation) [8]

Patient Experiences

Clinical trials provide information about patient experiences with Ketorolac Tromethamine:

Pain Relief

Patients in studies often report significant pain relief with ketorolac. For example, in studies using the Visual Analog Scale (VAS) for pain (where 0 represents no pain and 10 represents the worst pain imaginable), patients typically report meaningful reductions in pain scores after receiving ketorolac [14].

Tolerability

Studies have examined how well patients tolerate different formulations of ketorolac. For the intranasal form, research has explored different formulations to minimize nasal discomfort. For example, one study compared formulations with varying concentrations of lidocaine to reduce discomfort during administration [11].

Satisfaction

Patient satisfaction with pain management is an important outcome measure in clinical trials. Some studies have specifically assessed patient satisfaction with ketorolac treatment using standardized scales [19].

In conclusion, Ketorolac Tromethamine offers an effective non-opioid option for managing moderate to severe pain across various conditions. Its multiple routes of administration provide flexibility for different clinical situations, and its non-addictive nature makes it an important alternative in the context of concerns about opioid dependency. However, like all medications, it should be used under appropriate medical supervision, with attention to proper dosing, duration of treatment, and potential side effects.

Administration Route Formulations Conditions Studied Key Findings
Intranasal Spray (Sprix), solutions with varying lidocaine concentrations (0%, 4%, 6%) Postoperative pain, migraine, renal colic, interstitial cystitis – Effective for moderate to severe pain
– Reduced need for opioid rescue medication
– Weight-based dosing important in pediatric patients
– Addition of lidocaine may improve tolerability
– Pharmacokinetics in elderly vs. non-elderly studied
Intravenous Standard injection, continuous infusion (NTM-001) Postoperative pain, renal colic, acute pain – Lower doses (15mg) may be as effective as standard doses (30mg)
– Can be combined with morphine for enhanced pain relief
– Safety profile in different populations documented
– Continuous infusion being investigated
Topical Gel (2%), ophthalmic solution (0.4%, 0.5%) Gonarthrosis, low back pain, ocular inflammation, gouty arthritis – Effective for localized pain and inflammation
– Ocular formulations reduce inflammation after eye procedures
– Transcutaneous gel being studied for acute gout
– May have similar efficacy to other topical NSAIDs
Special Populations Various formulations with adjusted dosing Pediatric patients, elderly, postpartum women – Weight-based dosing for children (different doses for < 50kg vs. ≥ 50kg)
– Elderly may require dose adjustments due to altered pharmacokinetics
– Studied for post-cesarean pain management
– Doses as low as 10mg being investigated
Innovative Applications Various Cachexia in pancreatic cancer, pre-emptive analgesia – Being explored for anti-inflammatory effects beyond pain management
– Potential role in cachexia treatment for cancer patients
– Pre-surgical administration being studied for preventing pain cascade
– New delivery systems under development

Ongoing Clinical Trials on KETOROLAC TROMETAMOL

  • Testing acetylsalicylic acid and ketorolac to reduce complications after cancer surgery in patients with high inflammation levels

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Italy
  • Study on Reducing Post-Surgery Complications in Cancer Patients Using Ketorolac, Aspirin, and a Drug Combination

    Not yet recruiting

    1 1 1
    Italy
  • Study on Pain Management in Children Aged 7-18 with Acute Appendicitis Using Ketorolac Trometamol

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Latvia

Glossary

  • NSAID: Non-Steroidal Anti-Inflammatory Drug. A class of medications that reduce pain, inflammation, and fever by inhibiting enzymes called cyclooxygenases that produce inflammatory substances in the body. Ketorolac tromethamine belongs to this class.
  • Cyclooxygenase (COX) Inhibitor: A substance that blocks the cyclooxygenase enzymes (COX-1 and COX-2) that are involved in prostaglandin synthesis. Ketorolac is a non-selective COX inhibitor, meaning it blocks both COX-1 and COX-2 enzymes.
  • Renal Colic: Severe pain caused by a kidney stone blocking the flow of urine. The pain typically radiates from the flank to the groin and can be extremely intense. Clinical trials have studied ketorolac for treating this condition.
  • Intranasal Administration: Delivery of medication through the nose, where it's absorbed through the nasal mucosa. This route allows for rapid absorption into the bloodstream and can bypass the digestive system. Several ketorolac trials studied this delivery method.
  • Visual Analog Scale (VAS): A measurement tool used to assess pain intensity where patients mark their pain level on a continuous line, typically 10cm long, with one end representing 'no pain' and the other representing 'worst pain imaginable'. This was commonly used in ketorolac clinical trials to measure effectiveness.
  • Pharmacokinetics (PK): The study of how drugs move through the body, including absorption, distribution, metabolism, and excretion. Multiple ketorolac trials focused specifically on understanding its pharmacokinetic properties in different populations.
  • Cmax: The maximum concentration of a drug in the blood after administration. This pharmacokinetic parameter was measured in several ketorolac trials to understand how different formulations and doses affect blood levels.
  • Tmax: The time it takes for a drug to reach its maximum concentration in the blood after administration. This helps determine how quickly a medication begins working.
  • AUC (Area Under the Curve): A measure of total drug exposure over time, calculated from a graph of drug concentration in blood plotted against time. Higher AUC values indicate greater total exposure to the medication.
  • Patient-Controlled Analgesia (PCA): A method of pain control that allows patients to self-administer pain medication (usually through an IV) when needed. Several ketorolac trials used PCA systems to deliver rescue pain medication.
  • Multimodal Analgesia: The use of multiple different types of pain medications or techniques to achieve better pain control with fewer side effects than using a single method alone. Ketorolac is often studied as part of multimodal pain management approaches.
  • Rescue Medication: Additional pain medication given when the primary treatment doesn't provide adequate pain relief. Many ketorolac studies measured how much rescue medication (often opioids) patients required.
  • Scintigraphic Assessment: An imaging technique that uses radioactive tracers to visualize the distribution of a substance in the body. This was used in one study to track where intranasal ketorolac was deposited in the nasal cavity.
  • Selective Laser Trabeculoplasty (SLT): A laser procedure used to lower intraocular pressure in patients with open-angle glaucoma. One ketorolac trial studied its eye drop formulation for reducing inflammation after this procedure.
  • Double-Blind Study: A research design where neither the participants nor the researchers know which treatment is being administered, helping to prevent bias in assessing outcomes.
  • Pre-emptive Analgesia: The administration of pain medication before a painful stimulus (such as surgery) to prevent or reduce the development of pain signals and potentially improve pain control afterward.
  • Gonarthrosis: A medical term for osteoarthritis of the knee joint, characterized by pain, stiffness, and reduced mobility. Topical ketorolac gel was studied for this condition.
  • Interstitial Cystitis: A chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. One trial examined intranasal ketorolac for managing pain flares in this condition.

References

  1. https://clinicaltrials.gov/study/NCT01230463
  2. https://clinicaltrials.gov/study/NCT01542190
  3. https://clinicaltrials.gov/study/NCT01339624
  4. https://clinicaltrials.gov/study/NCT01363076
  5. https://clinicaltrials.gov/study/NCT00483717
  6. https://clinicaltrials.gov/study/NCT05641363
  7. https://clinicaltrials.gov/study/NCT06273813
  8. https://clinicaltrials.gov/study/NCT00478036
  9. https://clinicaltrials.gov/study/NCT02000401
  10. https://clinicaltrials.gov/study/NCT02638831
  11. https://clinicaltrials.gov/study/NCT01363063
  12. https://clinicaltrials.gov/study/NCT05336266
  13. https://clinicaltrials.gov/study/NCT01356212
  14. https://clinicaltrials.gov/study/NCT04441762
  15. https://clinicaltrials.gov/study/NCT01351090
  16. https://clinicaltrials.gov/study/NCT01291472
  17. https://clinicaltrials.gov/study/NCT02102516
  18. https://clinicaltrials.gov/study/NCT01365624
  19. https://clinicaltrials.gov/study/NCT02642718